Immediate Impact
57 standout
Citing Papers
Non-small-cell lung cancer
2024 Standout
Overall Survival with Osimertinib in Resected EGFR -Mutated NSCLC
2023 Standout
Works of Luca Luzzi being referenced
Surgical treatment of synchronous multiple lung cancer located in a different lobe or lung: high survival in node-negative subgroup☆
2009
Iterative surgical resections for local recurrent and second primary bronchogenic carcinoma✩
2000
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Luca Luzzi | 797 | 407 | 242 | 106 | 1.3k | |
| Masatsugu Hamaji | 886 | 471 | 354 | 183 | 1.5k | |
| Takekazu Iwata | 1036 | 488 | 220 | 75 | 1.6k | |
| Daniele Diso | 887 | 554 | 172 | 93 | 1.6k | |
| Venkata S. Katabathina | 486 | 577 | 310 | 68 | 1.3k | |
| Ashok Muniappan | 770 | 558 | 180 | 77 | 1.2k | |
| Stefano Bonardelli | 651 | 387 | 261 | 80 | 1.1k | |
| Usman Ahmad | 497 | 537 | 180 | 97 | 1.4k | |
| Luca Voltolini | 973 | 250 | 348 | 94 | 1.3k | |
| Takeharu Kato | 467 | 335 | 287 | 105 | 1.5k | |
| Emmanuel Martinod | 897 | 689 | 96 | 79 | 1.3k |
All Works
Login with ORCID to disown or claim papers
Loading papers...